Dividend Assets Capital’s Gilead Sciences GILD Stock Holding History

Dividend Assets Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-126	Closed	-$10K	–	495
2023 Q2	$10K	Buy	+126	New	+$10K	﹤0.01%	410
2021 Q1	–	Sell	-100	Closed	-$6K	–	538
2020 Q4	$6K	Buy	+100	New	+$6.03K	﹤0.01%	457
2017 Q2	–	Sell	-3,150	Closed	-$214K	–	161
2017 Q1	$214K	Sell	3,150 -150	-5%	-$10.5K	0.01%	156
2016 Q4	$236K	Buy	+3,300	New	+$245K	0.01%	137
2016 Q2	–	Sell	-2,652	Closed	-$244K	–	171
2016 Q1	$244K	Sell	2,652 -1,013	-28%	-$91.4K	0.01%	128
2015 Q4	$371K	Sell	3,665 -37	-1%	-$3.85K	0.01%	104
2015 Q3	$363K	Buy	3,702 +202	+6%	+$22.4K	0.01%	107
2015 Q2	$410K	Hold	3,500	–	–	0.01%	102
2015 Q1	$343K	Hold	3,500	–	–	0.01%	114
2014 Q4	$330K	Hold	3,500	–	–	0.01%	119
2014 Q3	$373K	Hold	3,500	–	–	0.01%	115
2014 Q2	$290K	Buy	3,500 +304	+10%	+$23.7K	0.01%	124
2014 Q1	$226K	Buy	3,196 +350	+12%	+$27.4K	0.01%	135
2013 Q4	$214K	Buy	+2,846	New	+$198K	0.01%	135

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dividend Assets Capital's GILD Position: Q3 2023 in Review

Dividend Assets Capital sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 126 shares — an estimated $10K sold.

Dividend Assets Capital first reported a position in GILD in Q4 2013 and held it in 14 quarters. The position peaked at $410K in Q2 2015. 1,683 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Dividend Assets Capital reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Dividend Assets Capital sold 126 Gilead Sciences shares in Q3 2023, an estimated $10K.
Dividend Assets Capital first reported a position in Gilead Sciences in Q4 2013 and held it in 14 quarters.
Dividend Assets Capital's Gilead Sciences position peaked at $410K in Q2 2015.
1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Dividend Assets Capital's 13F filing for Q3 2023, filed 26 Oct 2023.